Double stigma: a cross-sectional study of Lassa patients with hearing loss in North Central Nigeria.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 08 03 2024
accepted: 01 07 2024
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

Lassa fever is a zoonotic infectious disease endemic in West Africa with a high case-fatality rate and reported stigmatization of surviving patients. This study examines discrimination among survivors of Lassa fever (LF) complicated by hearing loss (HL). This cross-sectional qualitative study used an in-depth interview guide to collect information from patients with HL about their experience of stigma. Interviews were conducted by a trained team of interviewers at the Jos University Teaching Hospital between January and April 2022 in Hausa language after informed consent was obtained. Recordings of the interviews were transcribed and translated from Hausa to English. Data analysis was conducted using Most (73%) respondents were male ( There is a need to address stigma in LF survivors who develop HL through concerted community-owned awareness to improve their quality of life along with a robust social support system to aid prevention.

Identifiants

pubmed: 39076422
doi: 10.3389/fpubh.2024.1395939
pmc: PMC11284147
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1395939

Informations de copyright

Copyright © 2024 Best, Ameh, Weldon, Shwe, Maigari, Turaki, Ma’an, Yilgwan, Makishima, Weaver, Paessler and Shehu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Kachollom C Best (KC)

Department of Sociology, Faculty of Social Sciences, University of Jos, Jos, Nigeria.
West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Nigeria.

Emmanuel Ameh (E)

West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Nigeria.

Caroline Weldon (C)

Department of Microbiology, University of Texas Medical Branch, Galveston, TX, United States.

David Shwe (D)

Department of Paediatrics, Jos University Teaching Hospital, Jos, Nigeria.

Ibrahim Mahmood Maigari (IM)

Department of Internal Medicine, Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.

Ishaku Turaki (I)

Department of Otorhinolaryngology, Jos University Teaching Hospital, Jos, Nigeria.

Nuhu D Ma'an (ND)

Department of Otorhinolaryngology, Jos University Teaching Hospital, Jos, Nigeria.

Christopher Sabo Yilgwan (CS)

Department of Paediatrics, Jos University Teaching Hospital, Jos, Nigeria.

Tomoko Makishima (T)

Department of Ear, Nose and Throat, University of Texas Medical Branch, Galveston, TX, United States.

Scott Weaver (S)

Department of Microbiology, University of Texas Medical Branch, Galveston, TX, United States.

Slobodan Paessler (S)

Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.

Nathan Y Shehu (NY)

West African Center for Emerging Infectious Diseases, Jos University Teaching Hospital, Jos, Nigeria.
Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH